Epsilon M&A Deal Report - Mediprix
Transaction Multiples for the Valuation of Private Companies
Series B funding round backed by Nextstage AM / Mediprix
No EMAT :
113575
Announced Date :
06/07/2023
Type :
Acquisition of Minority Stake
Deal Value :
Yes
Acquirer :
Series B funding round backed by Nextstage AM
Target :
Mediprix
Country :
Hérault
Sector of activity :
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Founded by Bertrand Pages and Jérôme Escojido, Médiprix is a group of pharmacists. > Provides advice, assistance, and analysis to facilitate and develop the economic activity of its affiliates...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ||||||||
| Current |
Rating :
*
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 51
| Date | Acquirer | Target | Country | Multiples | See details |
| 15/05/2023 | Private group led by Nord Capital Investissement, Turenne Groupe, Sofipaca | Fresh Invest (Réseau Vitalis) | Nord | *** | 113483 |
| 02/06/2022 | CMO Group (Construction Materials Online) | Whiteholme (clickbasin.co.uk) | United Kingdom | ** | 112932 |
Source: Epsilon Research / EMAT
